Morrison & Foerster

Raft Receives Significant Growth Investment from Washington Harbour Partners

Retrieved on: 
Mittwoch, April 10, 2024
Technology, Finance, Security, Military, Professional Services, Software, Government Technology, Data Management, Defense, Artificial Intelligence, Intelligence, Investment, Morrison & Foerster, AI, MLS, Machine learning, Harbor, Partnership, Research, Federal, Workload, PwC, Data science, Culture, ABMS, Classification, Holland & Knight, Multimedia, Command, C2, Atmosphere, Control, Growth, Government, Management

Washington Harbour Partners LP (“Washington Harbour”), a leading private investment firm specializing in partnering with founders and management teams on unlocking their next phase of growth, announced today that it has made an over $60 million strategic growth investment in Raft LLC (“Raft”).

Key Points: 
  • Washington Harbour Partners LP (“Washington Harbour”), a leading private investment firm specializing in partnering with founders and management teams on unlocking their next phase of growth, announced today that it has made an over $60 million strategic growth investment in Raft LLC (“Raft”).
  • “We are thrilled to have the opportunity to partner with Shubhi and her team at Raft to help continue their incredible growth journey,” said Mina Faltas, Founder & Chief Investment Officer of Washington Harbour.
  • Raft will continue to be led by Founder & CEO, Shubhi Mishra, who remains a significant shareholder in the Company.
  • Washington Harbour was advised by Morrison & Foerster on legal matters and PwC on financial.

Nuvation Bio Completes Acquisition of AnHeart Therapeutics

Retrieved on: 
Mittwoch, April 10, 2024
Clinical Trials, Health Technology, Cardiology, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Oncology, Cancer, LLP, Partner, Cayman Islands, Morrison & Foerster, Haiwen & Partners, Entrepreneurship, Cayman, Patient, Acquisition, Fangda, Cooley LLP, Intellectual property, NUVB, Conyers, Georgia

Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of the acquisition of AnHeart Therapeutics Ltd. (AnHeart), a late-stage, global biopharmaceutical company developing novel precision therapies for people with cancer.

Key Points: 
  • Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of the acquisition of AnHeart Therapeutics Ltd. (AnHeart), a late-stage, global biopharmaceutical company developing novel precision therapies for people with cancer.
  • With the acquisition’s completion, AnHeart is now a wholly-owned subsidiary of Nuvation Bio.
  • “The closing of the acquisition transforms Nuvation Bio into a late-stage, global oncology company that is well-capitalized and positioned to develop our newly expanded pipeline as we move toward becoming a commercial organization,” said David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio.
  • Following completion of the acquisition, Nuvation Bio issued to the AnHeart security holders, in exchange for all outstanding AnHeart shares, options, and other securities, approximately 43,590,188 shares of Nuvation Bio’s Class A common stock (inclusive of the shares of Class A common stock underlying the AnHeart equity awards assumed by Nuvation Bio), 851,202 shares of Nuvation Bio’s Series A Non-Voting Convertible Preferred Stock (automatically convertible into 85,120,200 shares of Nuvation Bio’s Class A common stock upon the approval of Nuvation Bio’s stockholders), and warrants collectively exercisable for approximately 2,893,731 shares of Nuvation Bio’s Class A common stock at an exercise price of $11.50 per share.

Morrison Foerster Welcomes Experienced Derivatives Lawyer Rhys Bortignon as a Partner in New York

Retrieved on: 
Mittwoch, April 17, 2024
DEI, University, Mentorship, Capital market, Structured finance, OTC, Bachelor of Commerce, Master of Laws, Morrison & Foerster, Documentation, Mofo, Bachelor of Laws, Commerce, Consumer Protection Act, Knowledge

NEW YORK, April 17, 2024 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Rhys Bortignon as a partner in the firm's global Finance Group in the Transactions Department, based in the New York office. Bortignon brings to Morrison Foerster over 15 years of extensive knowledge and experience in derivatives and structured products in the United States, United Kingdom, European Union, and Australia.

Key Points: 
  • Bortignon brings to Morrison Foerster over 15 years of extensive knowledge and experience in derivatives and structured products in the United States, United Kingdom, European Union, and Australia.
  • Bortignon joins Morrison Foerster from another leading global law firm, where he spent the last nine years and was a member of its Capital Markets practice and Global Derivatives group.
  • "Morrison Foerster is a global finance industry leader, and I am honored to join the firm and its award-winning Capital Markets team," said Bortignon.
  • Bortignon frequently advises on U.S. derivatives regulatory matters, including matters related to the Dodd-Frank Wall Street Reform and Consumer Protection Act.

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

Retrieved on: 
Montag, März 25, 2024
Oncology, Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, NUVB, Morrison & Foerster, Partner, NMPA, Cayman Islands, Entrepreneurship, NSCLC, Patient, Conyers, Georgia, LLP, Haiwen & Partners, Acquisition, Cancer, Cooley LLP, Priority review, Fangda, Intellectual property, FDA, ROS1, Cayman, Food, Pharmaceutical industry

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, and AnHeart Therapeutics Ltd. (AnHeart), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced that the companies have entered into a definitive agreement for Nuvation Bio to acquire AnHeart in an all-stock transaction (the Acquisition).

Key Points: 
  • Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, and AnHeart Therapeutics Ltd. (AnHeart), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced that the companies have entered into a definitive agreement for Nuvation Bio to acquire AnHeart in an all-stock transaction (the Acquisition).
  • Immediately following the closing of the Acquisition, the former shareholders of AnHeart will own approximately 33% and the current stockholders of Nuvation Bio will own approximately 67% of Nuvation Bio on a fully diluted basis.
  • Subject to approval by the Nuvation Bio stockholders (the Nuvation Bio Stockholder Approval), each share of Series A Non-Voting Convertible Preferred Stock issued by Nuvation Bio in the Acquisition will initially be convertible into 100 shares of Class A common stock.
  • Any shareholders of AnHeart who are not accredited investors will receive cash for their AnHeart shares in lieu of receiving Nuvation Bio securities.

Morrison Foerster Adds Prominent Restructuring Partner Doug Mannal in New York

Retrieved on: 
Montag, März 11, 2024
Morrison & Foerster, Bankruptcy, Growth, Finance, Trust, Business, Transport, Chambers and Partners, Brooklyn Law School, Insurance, Shoe, Radio, Security (finance)

NEW YORK, March 11, 2024 /PRNewswire-PRWeb/ -- Morrison Foerster, a leading global law firm, is pleased to announce the arrival of Doug Mannal as a partner in the firm's Business Restructuring + Insolvency Group in the Transactions Department, based in the New York office. Mannal brings over 20 years of experience spanning all aspects of restructuring to the firm, with a particular focus on representing creditors, including official committees of unsecured creditors, as well as ad hoc groups of funds in distressed situations – both in and out of court. Mannal's arrival highlights the continued growth of Morrison Foerster's market-leading global restructuring capabilities and team. He is the second restructuring partner to join the firm's New York office this year, following the arrival of Oksana Lashko, last month.

Key Points: 
  • Mannal's arrival highlights the continued growth of Morrison Foerster's market-leading global restructuring capabilities and team.
  • He is the second restructuring partner to join the firm's New York office this year, following the arrival of Oksana Lashko, last month.
  • Mannal joins Morrison Foerster from another leading global law firm, where he was a member of the Financial Restructuring Group in New York and focused his practice on financial restructuring, representing a diverse range of clients in complex chapter 11 bankruptcy cases, out-of-court restructurings, and other distressed situations.
  • "Morrison Foerster is an exceptional firm with a standout restructuring team and a premier global platform," said Mannal.

Industry-Leading Employment Litigators Tritia Murata and David Zins Join Davis Wright Tremaine in Los Angeles

Retrieved on: 
Dienstag, März 5, 2024
Legal, Professional Services, Wake Forest University, Trailblazer, Woman, College, Multimedia, DEI, Chambers and Partners, Labour, Morrison & Foerster, Growth, Law360, The National Law Journal, Los Angeles Business Journal, Food, Harvard Law School, Private, PAGA, MVP, Employment, Labour law, Walking, Lawyer, UCLA School of Law, UCLA, Nursing

In a significant expansion of the firm’s national employment law practice, Davis Wright Tremaine LLP has added two renowned litigators to its team.

Key Points: 
  • In a significant expansion of the firm’s national employment law practice, Davis Wright Tremaine LLP has added two renowned litigators to its team.
  • Tritia M. Murata and David P. Zins have joined the firm as partners in Los Angeles, advancing the firm’s strategic growth in California.
  • They join a Davis Wright employment team that is one of the largest in the country, with nearly 100 lawyers, including 28 in Los Angeles.
  • Murata and Zins were both included in the 2023 Los Angeles Business Journal list of Leaders of Influence: Labor & Employment Attorneys.

Business and Securities Law Firm TroyGould Announces New Member Hires and Promotions

Retrieved on: 
Donnerstag, Februar 22, 2024
Professional Services, Legal, Business, Restaurant, Aviation, Sony Pictures, Harvard University, Harvard Law School, Yale Law School, University, M&A, Amy, Paramount Pictures, LLP, Morrison & Foerster, Summit Entertainment, Music

TroyGould, a nationally recognized business and securities law firm, proudly announces the addition of new Members Robyn L. Roth and Ilanna Bavli to its valued team and the well-deserved promotions of Tom Li and Amy Nashon.

Key Points: 
  • TroyGould, a nationally recognized business and securities law firm, proudly announces the addition of new Members Robyn L. Roth and Ilanna Bavli to its valued team and the well-deserved promotions of Tom Li and Amy Nashon.
  • A veteran entertainment and technology attorney, Ms. Bavli brings nearly 25 years of transactional legal experience to the firm.
  • Ms. Nashon joined TroyGould in 2020 with nearly two decades of legal experience and, after much success, has been promoted to Member at the firm.
  • The firm advises both U.S. and non-U.S. clients in their complex corporate, M&A, venture financing, securities and business litigation needs, including cross-border transactions.

Greenberg Traurig Adds Well-Known Attorney Jake Robson as Co-managing Shareholder and Head of M&A Practice in Singapore

Retrieved on: 
Mittwoch, März 6, 2024
Head, Private equity, King & Wood Mallesons, Investment, Fintech, LLP, Telecommunications, Morrison & Foerster, Publication

SINGAPORE, March 6, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP continues its strategic expansion in Southeast Asia with the addition of Jake Robson as co-managing shareholder of the Singapore office and head of the South and Southeast Asia Mergers & Acquisitions (M&A) Practice. Robson joins from King & Wood Mallesons where he developed and led its South and Southeast Asia Corporate and M&A practices. Previously, he developed the M&A practice in Singapore for Morrison & Foerster.

Key Points: 
  • Global law firm Greenberg Traurig, LLP continues its strategic expansion in Southeast Asia with the addition of Jake Robson as co-managing shareholder of the Singapore office and head of the South and Southeast Asia Mergers & Acquisitions (M&A) Practice.
  • SINGAPORE, March 6, 2024 /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP continues its strategic expansion in Southeast Asia with the addition of Jake Robson as co-managing shareholder of the Singapore office and head of the South and Southeast Asia Mergers & Acquisitions (M&A) Practice .
  • Robson joins from King & Wood Mallesons where he developed and led its South and Southeast Asia Corporate and M&A practices.
  • "Jake is a welcome addition to our global M&A Practice and he further strengthens the capabilities of our burgeoning Singapore office.

BOW RIVER CAPITAL'S SOFTWARE GROWTH EQUITY TEAM MAKES MAJORITY PLATFORM INVESTMENT IN ACCELO, A COMPREHENSIVE SAAS PSA PLATFORM FOR PROFESSIONAL SERVICES ORGANIZATIONS

Retrieved on: 
Donnerstag, Februar 29, 2024
AI, Professional services automation, Growth capital, Software as a service, Organization, Morrison & Foerster, PSA, Team, Capital, Acceleration, SGE, Bow River, Software

DENVER, Feb. 29, 2024 /PRNewswire/ -- Bow River Capital, a Denver-based alternative asset manager, announced today that its Software Growth Equity (SGE) Team has been selected by Accelo to partner in its next phase of scale, software and AI innovation. Founded 15+ years ago, Accelo's cloud-based system is an industry leading Professional Services Automation (PSA) suite to enable strategic insights, accurate and real-time decision-making, and best-in-class execution for all sizes of professional services organizations and their respective markets.

Key Points: 
  • Founded 15+ years ago, Accelo's cloud-based system is an industry leading Professional Services Automation (PSA) suite to enable strategic insights, accurate and real-time decision-making, and best-in-class execution for all sizes of professional services organizations and their respective markets.
  • Charles Chen, Partner at Level Equity said of the transaction, "We have high conviction in Accelo's future and are thrilled to partner with Bow River Capital to unlock the potential value ahead.
  • We're excited to participate in Accelo's next chapter of global growth with John Raeder and team."
  • Morrison & Foerster LLP served as legal counsel to Bow River Capital's Software Growth Equity Team on the transaction.

ANTHONY, LINDER & CACOMANOLIS HIRES CAPITAL MARKETS ATTORNEY CHRISTOPHER HINES

Retrieved on: 
Montag, Februar 12, 2024
PALM, Growth, Columbia Law School, Columbia Business Law Review, White, Yale University, DeBevoise, Shearman, Morrison & Foerster, Debevoise & Plimpton, Private investigator

WEST PALM BEACH, Fla., Feb. 12, 2024 /PRNewswire/ -- Anthony, Linder & Cacomanolis is proud to announce that the firm has hired seasoned capital markets and mergers and acquisitions attorney Christopher T. Hines.

Key Points: 
  • WEST PALM BEACH, Fla., Feb. 12, 2024 /PRNewswire/ -- Anthony, Linder & Cacomanolis is proud to announce that the firm has hired seasoned capital markets and mergers and acquisitions attorney Christopher T. Hines.
  • Hines has been practicing law since his 2002 graduation from Columbia University School of Law, which he attended after graduating with honors from Yale University.
  • He has specialized in capital markets and M&A work throughout his career, which includes stints at Debevoise & Plimpton, Morrison & Foerster, White & Case and Shearman & Sterling.
  • "I am excited and honored to join the team at Anthony, Linder & Cacomanolis, and contribute to their growing capital markets and mergers and acquisitions practices, particularly in respect of their Japanese practice and other cross-border matters," said Hines.